These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8923595)

  • 1. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raising awareness of Raynaud's phenomenon and scleroderma.
    Mawdsley AH; Brown SJ
    Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis.
    Pauling JD; Shipley JA; Harris ND; McHugh NJ
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S103-15. PubMed ID: 22691218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnosis of Raynaud's phenomenon.
    Wigley FM
    Hosp Pract (Off Ed); 1991 Jul; 26(7):63-70, 73-84. PubMed ID: 2071684
    [No Abstract]   [Full Text] [Related]  

  • 6. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1994 Nov; 6(6):603-6. PubMed ID: 7865380
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. French translation and linguistic validation of the Raynaud's condition score.
    Khouri C; Blaise S; Guigui A; Cracowski C; Allanore Y; Hachulla E; Senet P; Roustit M; Cracowski JL
    Therapie; 2019 Dec; 74(6):627-631. PubMed ID: 31023622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon and vascular disease in scleroderma.
    Kahaleh MB
    Curr Opin Rheumatol; 1994 Nov; 6(6):621-7. PubMed ID: 7865384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon. An update.
    Coffman JD
    Hypertension; 1991 May; 17(5):593-602. PubMed ID: 2022404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.